• Diagnosis​ ​Info​ ​and​ ​General​ ​Questions

  Request to Approve Duchenne MD Exon 53 Skipping Treatment, Viltolarsen, Before FDA

  Posted by md-forums-moderator on October 16, 2019 at 12:47 pm

  An application before the FDA seeks approval of viltolarsen, a weekly IV infusion treatment for Duchenne muscular dystrophy amenable to exon 53 skipping. Read more about it here.

  Are you excited about this news?

  md-forums-moderator replied 4 years, 6 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply